Data on residual clinical damage after Coronavirus disease-2019 (COVID-19) are lacking.
The aims of this study were to investigate whether COVID-19 leaves behind residual …

Abstract Many coronavirus disease 2019 (Covid-19) survivors show symptoms months after
acute illness. The aim of this work is to describe the clinical evolution of Covid-19, one year …

Objectives Little is known about the mental health outcomes of hospitalized COVID-19
patients. The aims of the study were:(1) to examine the trajectories of anxiety, depression …

We investigated the psychiatric symptomatology and the protracted symptoms in patients
who had recovered from the acute COVID-19 infection. Two hundred and eighty-four …

Purpose Few data are currently available on persistent symptoms and late organ damage in
patients who have suffered from COVID-19. This prospective study aimed to evaluate the …

Background Long-term effects of COVID-19, also called Long COVID, affect more than 10%
of patients. The most severe cases (ie those requiring hospitalization) present a higher …

Emerging evidence has shown that COVID-19 survivors could suffer from persistent
symptoms. However, it remains unclear whether these symptoms persist over the longer …

Objective: As the number of recovering COVID-19 patients increases worldwide, the
persistence of symptoms and signs through the post-acute phase indicates an urgent need …

Background Post-traumatic stress disorder (PTSD) is a severe but treatable mental disorder
that develops after a life-threatening traumatic event. Coronavirus disease 19 (COVID-19) …

This population-based study assessed the prevalence and determinants of symptom-
defined post-traumatic stress disorder (PTSD) in a cohort of hospitalized and non …